Literature DB >> 20725119

Plasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in children.

James A MacKenzie1, Kristen A Roosa, Brooks B Gump, Amy K Dumas, Kestutis G Bendinskas.   

Abstract

Plasma prekallikrein (PK) has been shown to be associated with cardiovascular disease (CVD) and its risk factors, but these associations have not been investigated in children. The present study examined PK activity in relation to well-established cardiovascular risk factors in a cohort of children aged 9-11 years (N=97). We found a significant and positive association between PK and fasting levels of total cholesterol (p<0.01), non-high-density lipoprotein cholesterol (p<0.01), and triglycerides (p<0.001). In addition, there was a significant association between PK activity and the metabolic syndrome, a clustering of risk factors considered to have an impact on atherosclerosis and CVD mortality. Finally, we found that children with a family history of CVD had significantly elevated PK activity. These novel findings warrant further investigations into the relationship between circulating PK levels and CVD risk factors because PK may be involved in the progression of the disease state.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20725119      PMCID: PMC4586083          DOI: 10.1139/H10-039

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  44 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 2.  American Heart Association Childhood Obesity Research Summit: executive summary.

Authors:  Stephen R Daniels; Marc S Jacobson; Brian W McCrindle; Robert H Eckel; Brigid McHugh Sanner
Journal:  Circulation       Date:  2009-03-30       Impact factor: 29.690

3.  Activation of the kallikrein system in hyperbetalipoproteinemia.

Authors:  A C Carvalho; R S Lees; R A Vaillancourt; R B Cabral; R W Colman
Journal:  J Lab Clin Med       Date:  1978-01

Review 4.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

5.  Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease.

Authors:  Christoph Merlo; Walter A Wuillemin; Maurice Redondo; Miha Furlan; Irmela Sulzer; Johanna Kremer-Hovinga; Bernd R Binder; Bernhard Lämmle
Journal:  Atherosclerosis       Date:  2002-04       Impact factor: 5.162

Review 6.  Effect of lipid modification on progression of coronary calcification.

Authors:  Peter A McCullough
Journal:  J Am Soc Nephrol       Date:  2005-11       Impact factor: 10.121

Review 7.  Origin of atherosclerosis in childhood and adolescence.

Authors:  H C McGill; C A McMahan; E E Herderick; G T Malcom; R E Tracy; J P Strong
Journal:  Am J Clin Nutr       Date:  2000-11       Impact factor: 7.045

8.  The link between high-fat meals and postprandial activation of blood coagulation factor VII possibly involves kallikrein.

Authors:  L F Larsen; P Marckmann; E M Bladbjerg; P B Ostergaard; J Sidelmann; J Jespersen
Journal:  Scand J Clin Lab Invest       Date:  2000-02       Impact factor: 1.713

9.  Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study.

Authors:  Isao Saito; Hiroyasu Iso; Yoshihiro Kokubo; Manami Inoue; Shoichiro Tsugane
Journal:  Circ J       Date:  2009-03-12       Impact factor: 2.993

10.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

Authors:  G S Berenson; S R Srinivasan; W Bao; W P Newman; R E Tracy; W A Wattigney
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

View more
  1 in total

1.  Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC.

Authors:  Miran A Jaffa; Ionut Bebu; Deirdre Luttrell; Barbara H Braffett; John M Lachin; Kelly Hunt; Maria Lopes-Virella; Louis Luttrell; Timothy J Lyons; Ayad A Jaffa
Journal:  Diabetes       Date:  2020-08-21       Impact factor: 9.461

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.